ATAI vs HBAN · rev $4.1M vs P/E 13, rev $1.56B
ATAI Life Sciences BV (ATAI) versus Huntington Bancshares Incorporated (HBAN) — a side-by-side from cached financials, not a winner call.
ATAI Life Sciences BV (ATAI) is a biotechnology company listed on US.
Huntington Bancshares Incorporated (HBAN) is a banks - regional company listed on US.
Latest reported ATAI revenue for 2025-12-31 was $4.1M. Net income was -$660.0M. Revenue was up 1227.6% from 2024-12-31 to 2025-12-31. ATAI currently screens at market cap $555.8M.
Latest reported HBAN revenue for 2025-12-31 was $1.56B. Net income was $2.21B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
ATAI currently screens at market cap $555.8M. HBAN currently screens at market cap $25.55B and trailing P/E 13.5.
Not investment advice. Open the ATAI and HBAN stock pages for the full models.
Not investment advice.